Literature DB >> 4810089

The administration of 5-fluorouracil by mouth.

H W Bruckner, W A Creasey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4810089     DOI： 10.1002/1097-0142(197401)33:1<14::aid-cncr2820330106>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  8 in total

1.  The chemotherapy of large-bowel cancer. Present status and future prospects.

Authors:  J Horton; C B Hacker; T J Cunningham; R W Sponzo
Journal:  Am J Dig Dis       Date:  1974-11

Review 2.  Clinical pharmacokinetics of systemic antifungal drugs.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

Review 3.  The practical benefits of pharmacokinetics in the use of antineoplastic agents.

Authors:  C Erlichman; R C Donehower; B A Chabner
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

Review 4.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

5.  Pharmacokinetics of 5-fluorouracil: inter-relationship with biochemical kinetics in monitoring therapy.

Authors:  W Sadee; C G Wong
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

6.  Fluorouracil therapy in patients with carcinoma of the large bowel: a pharmacokinetic comparison of various rates and routes of administration.

Authors:  N Chirstophidis; F J Vajda; I Lucas; O Drummer; W J Moon; W J Louis
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

7.  Regional and systemic serum concentrations of 5-fluorouracil after portal and intravenous infusion: an experimental study in dogs.

Authors:  B G Gustavsson; A Brandberg; C G Regårdh; O E Almersjö
Journal:  J Pharmacokinet Biopharm       Date:  1979-12

8.  Plasma levels of 5-fluorouracil after oral and intravenous administration in cancer patients.

Authors:  R E Finch; M R Bending; A F Lant
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.